Get the app
USHealthcare

Waystar Holding Corp. Common Stock (WAY)

US · Healthcare · Health Information Services

$26.51-0.30%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$319.7M
Revenue YoY
+18.1%
Net profit
$40.9M
Profit YoY
+27.0%
EPS
$0.37
EPS estimate
$0.35
Net margin
12.8%

EPS came in at 0.37 against a street estimate of 0.35 — a beat of 5.7%.

Key statistics

Market cap
$5.10B
P/E
38.0
Forward P/E
13.8
P/B
1.28
Book value
$20.54
EPS (TTM)
$0.70
52-week high
$40.35
52-week low
$17.26
50-day MA
$23.84
200-day MA
$24.93
Beta
0.15

Analyst view

Analysts rate Waystar Holding Corp. Common Stock a strong buy (13 buy, 0 hold, 0 sell out of 13) with an average price target of $33.30.

From the latest earnings call · 2026-07-29

CONFIDENT WAY delivered 18% YoY revenue growth to $320M, beat EBITDA expectations at 43% margin, raised FY26 guidance, and announced CFO transition. Strong bookings momentum in larger deals with AI solutions at ~40% of bookings. Q2 2026 No geographic segments disclosed; business operates nationally across US healthcare providers. Analysts probed competitive threats from EHR vendors, volume-based revenue deceleration, and capitalization of software spend. Management reframed as 'system of action' positioning, attributed volume slowdown to tough comps and normalized utilization, and emphasized disciplined AI investment balancing near-term margins with long-term leadership. 2026-07-29…

Full summary in the app.

Shareholding

Insiders
2.55%
Institutions
112.82%

Largest institutional holders

FundStake
EQT Fund Management S.à r.l.12.97%
Canada Pension Plan Investment Board9.92%
BlackRock Inc8.69%
FMR Inc7.80%
Bain Capital Investors LLC6.91%
Advent International LP5.77%
Vanguard Portfolio Management, LLC3.34%
Goldentree Asset Management LP3.21%

Recent filings & reports

DocumentDate
Quarterly report · Q2 2026
WAYSTAR HOLDING CORP. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q2 2026: $319.7 million (up 18.1% vs Q2 2025: $270.7 million) • Revenue H1 2
2026-07-29
Results announced · Q3 2026
WAYSTAR HOLDING CORP. - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 revenue: $319.7M, up 18% year-over-year • Q2 2026 net income: $40.9M (13
2026-07-29
Shareholder vote results · Q2 2026
WAYSTAR HOLDING CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held June 1, 2026 • 180,908,036 shares voted out of 191,685,290 entitled
2026-06-04
Quarterly report · Q1 2026
WAYSTAR HOLDING CORP. - Q1 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue Q1 2026: $313.9 million (up 22% from $256.4 million in Q1 20
2026-04-29
Results announced · Q2 2026
WAYSTAR Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $313.9M, up 22% year-over-year • GAAP net income: $43.3M (14% net margin) • Non-GAAP ne
2026-04-29
Proxy statement · Q4 2025
WAYSTAR HOLDING CORP. – 2026 PROXY STATEMENT SUMMARY CEO COMPENSATION & CHANGE • Total CEO Compensation (2025): $36.74 million • Breakdown: Base sal
2026-04-17
Annual report FY2025
WAYSTAR HOLDING CORP. - FORM 10-K SUMMARY (FY 2025) HEADLINE NUMBERS • Company: Waystar Holding Corp. (Ticker: WAY, Nasdaq), headquartered in Lehi,
2026-02-17
Results announced · Q1 2026
WAYSTAR HOLDING CORP. – Q4 2025 & FULL YEAR RESULTS SUMMARY HEADLINE NUMBERS • Q4 2025 Revenue: $303.5M, up 24% year-over-year • Full Year 2025 Reve
2026-02-17

Readable in the app.

Deals & corporate news

AnnouncementDate
Incremental term loans secured to fund acquisition of Iodine
Waystar Technologies completed the acquisition of Iodine on October 1, 2025, funded through a combination of debt and equity. To finance the deal, the company borrowed $250 million in new te
2025-10-01

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Waystar Holding Corp. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.